In the last 7 days
Pfizer’s $6.15B 3Sbio deal tops May’s biopharma activity BioWorld15:42 13-Jun-25
Fierce Pharma Asia—Pfizer CEO talks bispecific deal; Otsuka's kidney disease win; Novartis-MSN… FiercePharma10:34 13-Jun-25
A new era in migraine treatment: Innovative drugs redefining the field Labiotech09:10 13-Jun-25
PFE's New & Acquired Drugs Hold Key to Revenue Growth Amid Headwinds Zacks11:35 12-Jun-25
4 Cheap Dividend Stocks Under $50 That Keep Raising Payouts 24/7 Wall St.11:00 12-Jun-25
Legal-Bay Pre-Settlement Funding Investigates Emerging Lawsuits Against Depo-Provera Birth… PR Newswire (Press Release)06:09 12-Jun-25
May’s €1bn corporation tax hole can be summed up in one word: Pfizer The Currency00:35 12-Jun-25
Celltrion’s Rituxan biosimilar wins rare disease nod as Pfizer, Amgen land same-day OKs Korea Biomedical Review22:23 11-Jun-25
Pfizer: Dividend Investor's Dream And Patent Cliff Nightmare Seeking Alpha17:34 11-Jun-25
David Hung's Nuvation Bio wins FDA approval for Ibtrozi to challenge Pfizer, BMS and Roche in… FiercePharma16:33 11-Jun-25
Pfizer Scraps Bid for Depo-Provera Mass Tort Following Dismissal of Most Phila. Plaintiffs Law.com13:36 11-Jun-25
Critical Mass With Law.com's Amanda Bronstad: What's Next After Scotus Scraps LabCorp? Pfizer Hopes Federal Preemption… Law.com12:05 11-Jun-25
Pfizer Settles With Final Defendant in Mektovi Patent Lawsuit Bloomberg Law15:27 10-Jun-25
Saline in place of Pfizer vaccines? Health Ministry denies claims L'Orient-Le Jour12:35 10-Jun-25
NATO for medicines? Pfizer CEO calls for higher drug spending outside US amid Trump’s MFN… FiercePharma11:32 10-Jun-25
Pfizer launches Prevnar 20 for adults with Chong Kun Dang in Korea Korea Biomedical Review02:05 10-Jun-25
Rfk Jr. Cleans House: Fires Entire CDC Vaccine Advisory Panel Wall Street Pit20:03 9-Jun-25
Could Depo-Provera Cases Dwindle Due to Federal Preemption? Law.com17:38 9-Jun-25
No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says Reuters17:11 9-Jun-25
Letter to Senate Judiciary Committee Requesting Oversight Hearing into AG Pam Bondi’s Pfizer Conflicts Public Citizen14:50 9-Jun-25
‘Time to Listen’: Pfizer debuts video series about life with sickle cell disease FiercePharma14:00 9-Jun-25
Axsome plots new fibromyalgia trial after FDA refuses to review former Pfizer candidate FiercePharma13:00 9-Jun-25
Pfizer (PFE) Faces Tough Choices as Trump Targets U.S. Drug Prices TipRanks12:46 9-Jun-25
Pfizer, drug companies make 'no commitments' to White House about lowering drug prices Quartz12:12 9-Jun-25
Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip? Zacks11:26 9-Jun-25
Is Pfizer Stock Underperforming the S&P 500? Barchart09:17 9-Jun-25
Pfizer CEO says 'no commitments' made in meetings with US government on drug pricing Yahoo! UK & Ireland08:44 9-Jun-25
3 Stocks With Mouthwatering Dividends You Can Buy Right Now The Motley Fool06:39 8-Jun-25
In the last month
Should You Buy Pfizer Stock Right Now? The Motley Fool06:33 7-Jun-25
Federal Circuit Affirms PTAB’s Unpatentability Findings in Gene Therapy Hemgenix® IPRs JD Supra15:53 6-Jun-25
AM Best Affirms Credit Ratings of Blue Whale Re Ltd. Business Wire (Press Release)13:29 6-Jun-25
Will Pfizer Walk Away From Arvinas After PROTAC Disappointment? Scrip Pharma Intelligence11:39 6-Jun-25
Arvinas and Pfizer Submit New Drug Application TipRanks07:37 6-Jun-25
Arvinas Announces Submission Of NDA With Its Partner Pfizer For Vepdegestrant RTT News07:35 6-Jun-25
Zacks.com featured highlights JAKKS Pacific, Green Dot, Signet Jewelers, Gibraltar Industries and Pfizer Zacks06:22 6-Jun-25
Pfizer (NYSE:PFE) Exceeds Sales Milestone With Cresemba In Asia Pacific And China Simply Wall St20:02 5-Jun-25
With BMS and Pfizer joining the PD-1 bispecific race, Lilly and Novartis size up the hot cancer … FiercePharma07:59 5-Jun-25
Top Tech Jobs: Sony, Pfizer, Mason Hayes & Curran among those hiring Sunday Business Post05:31 5-Jun-25
Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis The Motley Fool03:41 5-Jun-25
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (June 2025) 24/7 Wall St.09:55 4-Jun-25
Pfizer Seeks Mass Tort Coordination of Phila. Depo-Provera Lawsuits Law.com14:50 3-Jun-25
Cere Investors Have the Opportunity to Lead the Cerevel Securities Fraud Lawsuit with Faruqi &… Business Wire (Press Release)09:46 3-Jun-25
3 Low-Priced Dividend Stocks Paying Over 5% Right Now 24/7 Wall St.09:11 3-Jun-25
Pfizer CEO goes to war with Rfk Jr over mRNA vaccines amid cancer link MailOnline11:58 2-Jun-25
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire (Press Release)10:02 2-Jun-25
Pfizer shares ‘unprecedented’ survival results for Braftovi in colorectal cancer PMLiVE07:36 2-Jun-25
Arvinas and Pfizer Announce Phase 3 Trial Results TipRanks06:36 2-Jun-25
Pfizer taps GC Biopharma to distribute Covid-19 pill in Korea Korea Biomedical Review00:34 2-Jun-25
A funding flashpoint, Pfizer’s $1B poster and AstraZeneca advertising BioPharma Dive12:14 1-Jun-25
400 Women Are Suing Pfizer Over Birth Control Shot That Allegedly Gave Them Brain Tumors Futurism10:32 1-Jun-25
Terrible News for Pfizer Stock Investors The Motley Fool09:17 1-Jun-25
ASCO 25: Braftovi shows "unprecedented" survival gain pharmaphorum06:50 1-Jun-25
The presence of neutralizing antibodies against omicron subvariants among a vaccinated cohort at one year after the… Nature.com01:09 1-Jun-25
STAT Plus: ASCO day 2: A tragic paradox, Gilead updates, and lots of Pfizer news STAT17:20 31-May-25
Breast cancer: Pfizer-Arvinas drug beats AstraZeneca’s in delaying disease’s progression The Hindu Business Line08:54 31-May-25
#ASCO25: Arvinas, Pfizer's PROTAC in breast cancer no better than oral SERDs ENDPOINTS08:10 31-May-25
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant,… Pfizer (Press Release)08:08 31-May-25
Former Pfizer Atty, Motley Rice Adviser, Joins DiCello Levitt Law36016:06 30-May-25
ASCO25: Pfizer’s Braftovi combo boasts 47% drop in disease progression in mCRC Pharmaceutical Technology11:35 30-May-25
ASCO: Pfizer, chasing full approval conversion for Braftovi combo, touts 'unprecedented'… FiercePharma08:18 30-May-25
#ASCO25: Pfizer's Braftovi combo doubles survival time for some colorectal cancer patients ENDPOINTS08:06 30-May-25
Pfizer’s Braftovi® Combination Regimen Cuts the Risk of Death in Half for Patients with Braf… Business Wire (Press Release)08:03 30-May-25
Onc.AI to Present Breakthrough Deep Learning Radiomic Biomarker Results at 2025 ASCO Annual… Business Wire (Press Release)06:10 30-May-25
Popular medicine taken by millions of women every year has given them Brain tumors MailOnline21:28 29-May-25
Pfizer again found to have discredited pharma industry with COVID-19 vaccine tweets FiercePharma10:26 29-May-25
5 Rock-Solid Dividend Stocks Under $50 With Room to Run 24/7 Wall St.09:00 29-May-25
Old COVID tweet lands Pfizer in new trouble with PMCPA pharmaphorum08:40 29-May-25
Schizophrenia Drugs Market Research Report 2025-2035, Competitive Analysis of Prominent Players … Business Wire (Press Release)14:50 28-May-25
Pfizer and BioNTech Submit EMA Application for COVID-19 Vaccine Targeting LP.8.1 for 2025-2026… BioNTech (Press Release)06:46 28-May-25
Unlocking Pfizer's Value: Cost Controls And Oncology Pipeline Seeking Alpha03:13 28-May-25
Pfizer CEO: no commitments made in drug price meetings with US government Reuters14:32 27-May-25
Comment to the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) regarding the 2025-2026 formula … Public Citizen11:48 27-May-25
Is Pfizer Stock a Buy After This $1.25 Billion Investment? The Motley Fool10:04 27-May-25
Pfizer headquarters conversion project in Manhattan gets $720m loan World Construction Network04:44 27-May-25
Investing In The Promising PD1/VEGF Bispecific - Pfizer And Instil Could Be Good Candidates Seeking Alpha09:19 26-May-25
Pfizer beaten at Korean Supreme Court in vaccine patent dispute IAM21:11 25-May-25
Down 63%, Should You Buy the Dip on Pfizer? The Motley Fool08:54 24-May-25
Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and Covid-19 Nature.com03:51 24-May-25
Pfizer's 7.5% Dividend: Income Haven or House of Cards? Entrepreneur Magazine20:21 23-May-25
Gensler to convert 5 Times Square, the former Ernst & Young headquarters, into housing The Architect's Newspaper14:24 23-May-25
Fierce Pharma Asia—Pfizer's PD-1xVEGF bet; An Alzheimer's blood test approval; Samsung's biosim … FiercePharma09:06 23-May-25
Pfizer Stock Analysis: Buy, Sell, or Hold? The Motley Fool08:06 23-May-25
Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial Clinical Trials Arena06:29 23-May-25
Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study… PR Newswire (Press Release)00:23 23-May-25
Fed. Circ. Backs Pfizer Win Against Gene Therapy Patents Law36020:48 22-May-25
The Pros and Cons of the Latest FDA Actions on COVID Vaccines NEJM Journal Watch17:24 22-May-25
Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic… PR Newswire (Press Release)17:04 22-May-25
FDA: Add Heart Risk to COVID Shot Warning Label NewsMax15:18 22-May-25
Pfizer Cements Win Axing Hemophilia Patents at Federal Circuit Bloomberg Law15:01 22-May-25
Trump's FDA drops Covid vaccine bombshell as Pfizer and Moderna admit heart damage risk MailOnline11:00 22-May-25
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines HealthDay10:25 22-May-25
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population FiercePharma10:24 22-May-25
Executives On The Move: Capricor Therapeutics Acquires Chief Medical Officer From Pfizer, Galapagos And Cellarity Get A … Scrip Pharma Intelligence10:03 22-May-25
Pfizer's weekly haemophilia drug backed for NHS use pharmaphorum07:09 22-May-25
FDA tightens heart tox warnings on mRNA COVID vaccines pharmaphorum06:19 22-May-25
NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS Pharmafile05:54 22-May-25
Mixed outcomes for pharma in big week for FDA adcomms pharmaphorum05:28 22-May-25
Dixon Tech, ICICI Securities & more: Top stocks on broker's radar for May 22 The Times of India00:23 22-May-25
Pfizer's Lorviqua wins insurance coverage for 1st-line ALK-positive NSCLC in Korea Korea Biomedical Review22:46 21-May-25
FDA adcomm votes unanimously against Pfizer's prostate cancer drug combo ENDPOINTS20:21 21-May-25
Pfizer Hits FDA Setback in Effort to Boost Prostate Cancer Drug Bloomberg Law17:19 21-May-25
Pfizer reminds UK healthcare workers that LGBTIQ+ patients are 'More Than Cancer' in new… FiercePharma14:44 21-May-25
FDA expands Covid vaccine warning about possible side effect CBS News12:17 21-May-25
The Zacks Analyst Blog Highlights Pfizer, Coca-Cola and The Walt Disney Zacks10:17 21-May-25
NICE recommends Pfizer once-weekly treatment for haemophilia B on NHS European Pharmaceutical Manufacturer10:14 21-May-25
SK defeats Pfizer in Korean patent feud, opening new lines of business for pneumococcal vaccine FiercePharma09:49 21-May-25
South Korean biotechnology firm wins patent case against Pfizer over vaccine components Anadolu Agency09:37 21-May-25
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine PR Newswire (Press Release)08:01 21-May-25
Pfizer gains rights to 3SBio’s investigational bispecific antibody in deal worth over $6bn PMLiVE07:34 21-May-25
International and Regional Experts Focus on RSV Prevention at Pfizer MERA Maternal Immunization … PR Newswire (Press Release)06:04 21-May-25
Chinese biotech firm secures US$6 billion Pfizer deal for cancer drug South China Morning Post06:02 21-May-25
This Week's N.Y. Deal Sheet: Madison Realty Capital Lends $720M On Pfizer HQ Conversion Bisnow04:34 21-May-25
SK bioscience wins patent dispute against Pfizer over pneumococcal vaccine Korea JoongAng Daily00:25 21-May-25
Pfizer signs $1.25bn cancer antibody licensing deal with China's 3SBio FinanceAsia23:58 20-May-25
Covid vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers Yahoo! US16:17 20-May-25

      
            
      
    view more headlines
   
      
      
      
13 Jun 15:42
   
Pfizer News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Pfizer news, covering the latest share price, vaccine news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
Pfizer

Latest News

Pfizer News

Pharmaceuticals Top Stories

Business Top Stories
